Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple Myeloma

BACKGROUND: Multiple myeloma (MM) is the second most common hematologic cancer with poor prognosis. Novel therapeutic strategies are needed to decrease the high mortality rate. The aim of this study was to identify prospective agents for MM. MATERIAL/METHODS: A microarray dataset was mined, which co...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Fang-xiao, He, Yu-chan, Zhang, Jun-yan, Wang, Hang-fei, Zhong, Chen, Wang, Xiao-tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510057/
https://www.ncbi.nlm.nih.gov/pubmed/31048671
http://dx.doi.org/10.12659/MSM.913970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510057/
https://www.ncbi.nlm.nih.gov/pubmed/31048671
http://dx.doi.org/10.12659/MSM.913970

Ejemplares similares